NCT00692055View on ClinicalTrials.gov

Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Arthritis

Interventions

DRUG

PN400

naproxen 375 mg / esomeprazole 20 mg

DRUG

Naproxen

naproxen 375 mg

Trial Locations (1)

Unknown

Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

POZEN

INDUSTRY